Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004800 220001890 1.86 67.3 Palliative (P) 2013-04-19 2013-04-20 Cytarabine Low Dose N N 220026802 CYTARABINE
220004801 220001890 1.63 null Palliative (P) 2013-11-29 2013-11-29 Trial Unspecified Y N 220026802 TRIAL
220004802 220001890 null 87.9 Curative (C) 2017-05-15 2017-05-15 Trial Unspecified 01 N 220026802 TRIAL
220004803 220001890 null 98 Curative (C) 2014-04-21 2014-04-21 AML17 TRIAL 2 N 220026802 AML17 TRIAL
220004804 220001890 1.63 87.5 Palliative (P) 2016-11-27 2016-11-27 Trial Unspecified Y N 220026802 TRIAL
220004805 220001891 1.76 66.1 Palliative (P) 2013-03-28 2013-04-03 Trial Unspecified Y N 220026816 TRIAL
220004806 220001891 1.92 76 null 2015-12-11 2015-12-14 AML17 TRIAL null N 220026816 AML17 TRIAL
220004807 220001891 1.65 102.5 Curative (C) 2014-05-21 2014-06-12 Trial Unspecified Y N 220026816 TRIAL
220004808 220001891 null 78.8 Not known (9) 2013-02-27 2013-03-05 AML17 TRIAL 02 N 220026816 AML17 TRIAL
220004810 220001893 1.83 78 Palliative (P) 2015-05-06 2015-05-06 AML17 TRIAL 1 N 220026833 AML17 TRIAL
220004811 220001893 1.87 null Curative (C) 2012-12-20 2013-09-16 AML17 TRIAL N N 220026833 AML17 TRIAL
220004812 220001894 null 60.2 Adjuvant (A) 2017-08-29 2017-09-04 AML17 TRIAL N N 220026836 AML17 TRIAL
220004813 220001894 1.7 63 null 2017-01-18 2017-01-18 AML17 TRIAL N N 220026836 AML17 TRIAL
220004815 220001896 1.73 95.3 Curative (C) 2014-12-12 2014-12-12 AML17 TRIAL 01 N 220026839 AML17 TRIAL
220004816 220001896 1.67 88.4 null null 2016-02-12 AML17 TRIAL 02 null 220026839 AML17 TRIAL
220004818 220010978 0 68 null 2015-12-02 2015-12-17 Cytarabine Low Dose N N 220026845 CYTARABINE
220004819 220001898 null null Palliative (P) null 2015-10-26 CYTARABINE N N 220026846 CYTARABINE
220004820 220001899 1.68 78 null 2016-03-31 2016-03-31 AML17 TRIAL 02 N 220026853 AML17 TRIAL
220004821 220001900 null 96.6 Curative (C) 2015-08-09 2015-08-12 AML17 TRIAL N N 220026855 AML17 TRIAL
220004822 220001901 null 0 Palliative (P) 2015-02-12 2015-02-12 CYTARABINE Y Y 220026856 CYTARABINE
220004823 220010979 1.57 75 Disease modification (D) 2016-10-01 2016-10-01 Cytarabine low (10to20mg/m2) IV/SC null null 220026862 CYTARABINE
220004824 220010979 1.8 59.5 Disease modification (D) 2017-11-06 2017-11-12 AML17 TRIAL Y N 220026862 AML17 TRIAL
220004825 220001902 1.7 null Palliative (P) 2015-07-20 2015-08-01 Cytarabine Low Dose 02 N 220026867 CYTARABINE
220004826 220001902 1.53 76 Palliative (P) 2014-02-26 2014-02-26 CYTARABINE N N 220026867 CYTARABINE
220004827 220015860 1.65 null Palliative (P) 2017-12-14 2017-12-29 CYTARABINE N N 220026874 CYTARABINE
220004828 220015860 1.56 57.1 Palliative (P) 2013-12-13 2013-12-20 Cytarabine Low Dose N N 220026874 CYTARABINE
220004829 220015860 1.6 null null 2016-04-26 2016-04-26 Trial Unspecified 1 N 220026874 TRIAL
220004830 220015860 1.64 102.3 null 2016-01-12 2016-01-15 Cytarabine Low Dose 02 null 220026874 CYTARABINE
220004831 220015860 1.41 66.4 Not known (9) 2013-11-03 2013-11-05 Trial Unspecified Y null 220026874 TRIAL
220004832 220001903 1.76 null Disease modification (D) 2015-04-28 2015-05-03 AML17 TRIAL N N 220026889 AML17 TRIAL
220004833 220001904 1.86 60.9 Curative (C) 2017-05-31 2017-05-31 Trial Unspecified 01 null 220026890 TRIAL
220004834 220010981 1.6 70 Palliative (P) 2016-04-26 2016-04-26 CYTARABINE null N 220026891 CYTARABINE
220004837 220001906 null 95.6 Curative (C) 2013-06-26 2013-06-27 LI-1 TRIAL Y null 220026894 TRIAL
220004838 220001906 null 73.5 Curative (C) 2016-08-28 2016-08-28 Trial Unspecified 01 N 220026894 TRIAL
220004839 220015861 0 58.5 Curative (C) 2014-05-07 2014-07-05 AML17 TRIAL 2 null 220026897 AML17 TRIAL
220004840 220001907 1.75 88.6 Curative (C) 2017-02-23 2017-02-23 Trial Unspecified Y N 220026899 TRIAL
220004841 220001907 null 104 null 2014-03-24 2014-03-27 Cytarabine Low Dose 2 N 220026899 CYTARABINE
220004842 220001907 1.81 82.4 Curative (C) 2016-12-30 2017-01-02 Trial Unspecified 1 N 220026899 TRIAL
220004843 220001908 0 null null 2015-09-14 2015-09-14 Cytarabine low (10to20mg/m2) IV/SC N N 220026910 CYTARABINE
220004844 220001908 1.67 null Palliative (P) 2017-09-17 2017-09-22 Cytarabine low (10to20mg/m2) IV/SC 99 N 220026910 CYTARABINE
220004845 220015863 1.67 83.3 Curative (C) 2017-04-02 2017-04-12 Trial Unspecified Y N 220026919 TRIAL
220004846 220001909 1.76 75 null 2015-01-19 2015-01-19 Trial Unspecified 01 N 220026921 TRIAL
220004847 220001909 1.55 0 Curative (C) 2015-07-15 2015-07-16 Trial Unspecified 01 N 220026921 TRIAL
220004848 220001910 1.68 77 Curative (C) 2015-08-19 2015-08-24 Trial Unspecified Y N 220026923 TRIAL
220004849 220001910 1.78 81.2 Adjuvant (A) 2015-10-04 2015-10-09 Cytarabine Low Dose 99 N 220026923 CYTARABINE
220004850 220001910 null 75.6 Curative (C) 2016-03-10 2016-03-10 Cytarabine Low Dose N N 220026923 CYTARABINE
220004851 220018698 1.62 90 Palliative (P) 2016-07-04 2016-07-04 Trial Unspecified 1 N 220026928 TRIAL
220004852 220001911 1.81 55 Curative (C) 2017-11-06 2017-12-20 AML17 TRIAL N N 220026929 AML17 TRIAL
220004853 220001911 null null Curative (C) 2017-05-04 2017-05-04 CYTARABINE N N 220026929 CYTARABINE
220004854 220001911 null null Palliative (P) 2014-05-10 2014-05-10 Cytarabine Low Dose 02 N 220026929 CYTARABINE